Načítá se...
Improved Protein Kinase C Affinity through Final Step Diversification of a Simplified Salicylate-Derived Bryostatin Analog Scaffold
[Image: see text] Bryostatin 1, in clinical trials or preclinical development for cancer, Alzheimer’s disease, and a first-of-its-kind strategy for HIV/AIDS eradication, is neither readily available nor optimally suited for clinical use. In preceding work, we disclosed a new class of simplified bryo...
Uloženo v:
| Vydáno v: | Org Lett |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334251/ https://ncbi.nlm.nih.gov/pubmed/25238640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ol502492b |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|